CARDINAL HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 98.06 USD | +0.64% |
|
-4.78% | -2.72% |
| May. 07 | Cardinal Health Board of Directors Approves Increase to Quarterly Dividend, Payable on July 15, 2024 | CI |
| May. 07 | Deutsche Bank Adjusts Price Target on Cardinal Health to $110 From $116 | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 226B | Sales 2025 * | 213B | Capitalization | 23.73B |
|---|---|---|---|---|---|
| Net income 2024 * | 955M | Net income 2025 * | 1.45B | EV / Sales 2024 * | 0.11 x |
| Net Debt 2024 * | 732M | Net cash position 2025 * | 376M | EV / Sales 2025 * | 0.11 x |
| P/E ratio 2024 * |
24.7
x | P/E ratio 2025 * |
15.6
x | Employees | 47,520 |
| Yield 2024 * |
2.07% | Yield 2025 * |
2.1% | Free-Float | 74.15% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cardinal Health, Inc.
More recommendations
More press releases
| 1 day | +0.64% | ||
| 1 week | -4.78% | ||
| Current month | -4.83% | ||
| 1 month | -9.26% | ||
| 3 months | -6.57% | ||
| 6 months | -4.62% | ||
| Current year | -2.72% |
1 week
97.31
102.26
1 month
97.31108.57
Current year
97.31116.04
1 year
80.90116.04
3 years
45.85116.04
5 years
39.05116.04
10 years
39.05116.04
| Managers | Title | Age | Since |
|---|---|---|---|
Jason Hollar
CEO | Chief Executive Officer | 51 | 20-04-26 |
Aaron Alt
DFI | Director of Finance/CFO | 53 | 23-02-09 |
Michelle Greene
CTO | Chief Tech/Sci/R&D Officer | 54 | 20-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 22-09-05 | |
| Director/Board Member | 71 | 13-09-11 | |
Gregory Kenny
CHM | Chairman | 71 | 06-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 97.44 | -2.29% | 2,280,705 |
| 24-05-07 | 99.72 | +1.15% | 2,307,955 |
| 24-05-06 | 98.59 | -0.32% | 1,889,759 |
| 24-05-03 | 98.91 | -3.95% | 3,446,183 |
| 24-05-02 | 103 | +0.79% | 3,684,813 |
Delayed Quote Nyse, May 09, 2024 at 04:00 pm EDT
More quotes
Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows:
- distribution of pharmaceutical products (92.7%);
- distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.).
The United States accounts for 97.7% of net sales.
Sector
Pharmaceuticals
Calendar
2024-05-14
- BofA Securities Health Care Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
97.44
USD
Average target price
112.4
USD
Spread / Average Target
+15.31%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.72% | 23.73B | |
| +1.47% | 8.28B | |
| +8.61% | 8.26B | |
| -18.57% | 8.07B | |
| +5.56% | 4.8B | |
| +19.12% | 4.26B | |
| -3.24% | 4.08B | |
| -1.86% | 3.92B | |
| +26.66% | 3.68B | |
| +8.01% | 3.3B |
- Stock Market
- Equities
- CAH Stock